Truffle Capital is a venture capital and private equity firm investing in technology companies that is headquartered in Paris, France and was founded in 2001 by Bernard-Louis Roques, Henri Moulard, Jean-Francois Fourt, and Philippe Pouletty. According to the firms website 9 (as of December 2019), Truffle Capital has €500 under management, has made 75 investments since its founding, and has 24 employees.
The firm focuses on investing in information technology, financial technology, insurance technology, biotechnology, and medical technology companies.
Altimmune is a therapeutics, treatment, and vaccine development company that looks to find response and prevention solutions
Theradiag is a France-based medical diagnostics company developing tracker kits and biotherapy monitoring kits.